This week, we will discuss the ADVOCATE trial. Avacopan is not just a flash in the pan? We hope so, having won the RheumMadness and offering a steroid free hope.
This week, we will discuss the use of renal autologous cell therapy (REACT) in diabetic kidney disease.
This week, we will discuss 2026 KDIGO anemia management in patients with kidney disease
This week, we aim for an INFINITe allograft lifespan. or flozination in kidney transplant.
This week, we will discuss the POTCAST trial. It is a cardiology trial - but potassium belongs to nephrology.